Navigation Links
Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
Date:4/25/2008

interest received on cash and cash equivalents. Interest income for the three months to March 31, 2008 is lower than the same period in 2007 due to lower average cash and cash equivalent balances and lower average US Dollar interest rates.

Interest expense

For the three months to March 31, 2008 the Company incurred interest expense of $17.3 million (2007: $7.8 million). The increase in interest expense compared to the same period in 2007 mainly relates to Shire's US$1,100 million principal amount 2.75% convertible bonds which were issued in May 2007.

In both three month periods to March 31, 2008 and 2007 interest expense includes a provision for interest, which may be awarded by the Court in respect of amounts due to those ex-Transkaryotic Therapies, Inc. ("TKT") shareholders who have requested appraisal of the acquisition consideration payable for their TKT shares. The trial date of May 12, 2008 has been postponed and no new trial date has been set. Further information on this litigation can be found in our filings with the SEC, including our Annual Report on Form 10-K for the year to December 31, 2007.

Other income

Other income includes a gain of $9.4 million arising from the sale of Shire's minority equity investment in Questcor Pharmaceuticals Inc., a specialty pharmaceutical company focused on providing prescription drugs for central nervous system (CNS) disorders. The disposal generated cash consideration of $10.3 million.

Taxation

The effective rate of tax for the three months to March 31, 2008 was 26% (2007: 27%). Excluding the tax effect of items excluded from non GAAP income as outlined on pages 24-25, the effective rate of tax on non GAAP income is 28% (2007: 27%). Shire reaffirms its previous guidance (issued as part of the 2007 year end results) that the full year effective tax rate on non GAAP income is expected to be approximately 23% (2007: 21%).

Equity in earnings of equity method investees '/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
3. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
4. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
5. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
6. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
7. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
8. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
9. ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model
10. Optherion, Inc. Completes $37 Million Start Up Financing
11. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... the latest particle size distribution technologies, including the new C35 ... AAPS 2010. , ... (PRWEB) December ... American Association of Pharmaceutical Scientists’ Annual Meeting, AAPS 2010 ... Booth 612 at AAPS 2010 to see the latest particle ...
(Date:12/16/2009)... It has passed as fact among historians, journalists and ... to the floor of the U.S. Congress: British forces ... I. , But that claim has never been ... Douglas, a historian at Colgate University. According to Douglas,s ... Journal of Modern History , no such incident ever ...
(Date:12/16/2009)... University of East Anglia (UEA) could contribute to the ... to generate clean electricity. , Published today by the ... of Sciences (PNAS), the researchers have demonstrated for ... survive by ,breathing rocks,. , The findings could be ... technologies such as fuel cells, or ,bio-batteries, powered by ...
(Date:12/16/2009)... Blood loss is a major cause of death from ... cause of death for people age 4 to 44, ... an effort to enhance the natural process, a team ... University biomedical engineering professor, and her former doctoral student, ... in halting internal and external bleeding., Their work is ...
Breaking Biology Technology:Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4'Rock-breathing' bacteria could generate electricity and clean up oil spills 2Researchers take the inside route to halt bleeding 2
... New Progression-Free Survival Data Support Picoplatin in ... Metastatic Castration-Resistant Prostate Cancer -- Results To ... Clinical Oncology,s 2009 Genitourinary Cancers Symposium -SOUTH ... Pharmaceuticals, Inc. (Nasdaq: PARD ), ...
... 25 Arpida Ltd,(SIX: ARPN) announced today its financial results for the year ... - Setback in regulatory process for intravenous iclaprim in US, ... - Top-line results of "intravenous-to-oral" Phase II trial with oral, ... - Leadership change, - Share placing, ...
... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading ... and stem cell research systems, today announced positive ... These validation results were presented today by ... University of Pittsburgh School of Medicine as ...
Other Biology Technology:Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 2Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 3Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 4Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 5Arpida Announces Full Year 2008 Financial Results 2Arpida Announces Full Year 2008 Financial Results 3Arpida Announces Full Year 2008 Financial Results 4Arpida Announces Full Year 2008 Financial Results 5Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 2Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 3Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 4Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference 5
(Date:12/16/2009)... can undergo a personality change in warmer water, according ... may make some species more aggressive. , Experiments with ... Reef have shown for the first time that some ... and that these individual differences are even more marked ... just one or two degrees may have only a ...
(Date:12/16/2009)... (Climate-KIC)" is a major initiative the EIT has announced ... expertise of world class partners in a shared effort ... meet the climate change challenge in the years to ... In responding to this challenge, we need to bring ... goods, and to how we meet our requirements for ...
(Date:12/16/2009)... the most out of every drop of water is a high ... are hot and dry and vines have to be irrigated to ... that a significant portion of the water applied to the vines ... found that about 10 percent of the water that is applied ... contact with the soil and vine roots," said Eve Hinckley, who ...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Innovation boost to tackle climate change 2Innovation boost to tackle climate change 3Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4How to Change Someone You Love Offers Help to Those Who Feel Powerless in the Face of Addiction 49684 1How to Change Someone You Love Offers Help to Those Who Feel Powerless in the Face of Addiction 49684 2FDAs Current Ability to Regulate Genetic Testing is Problematic FDLI AAAS Colloquium Attendees Say 49681 1FDAs Current Ability to Regulate Genetic Testing is Problematic FDLI AAAS Colloquium Attendees Say 49681 2FDAs Current Ability to Regulate Genetic Testing is Problematic FDLI AAAS Colloquium Attendees Say 49681 3YWCAs to Promote United We Serve Initiative June 22 September 11 49678 1YWCAs to Promote United We Serve Initiative June 22 September 11 49678 2
... and greenhouse producers, landscape services firms, and wholesale ... past two decades, becoming an increasingly important sector ... Industry generated 1.96 million jobs and $147.8 billion ... and greenhouse crops reached $16.9 billion. Despite its ...
... CASince around 1960, methyl bromide (MB) has been the ... strawberries. MB, classified as a Class I stratospheric ozone-depleting ... still being used in strawberry production under a critical-use ... the state leads the U.S. in strawberry production. In ...
... Experts will gather at Duke University March 2-3 to ... today, ranging from national security to education and energy. ... Challenges for Engineering report ( http://www.engineeringchallenges.org/ ) issued last ... detailed how engineering has and will play a critical ...
Other Biology News:Results of national nursery survey unveiled 2Methyl bromide alternatives for California strawberry nurseries 2Duke forum to address global engineering problems 2
... (HSC) are well-characterized tissue-specific stem cells that ... for the life-long maintenance of the hematopoietic ... in adult bone marrow where hematopoiesis is ... found in cord blood, fetal liver, adult ...
... Rabbit polyclonal to Atrophin 1 ( Abpromise ... Antigen: Synthetic peptide conjugated to ... the C-terminus of Human Atrophin 1.(Note: the ... ab32861 .) Entrez ...
NNT-1/BSF-3 (N-14)...
This antibody detects an ~92 kDa protein corresponding to the apparent molecular mass of the beta subunit of Hypoxia Inducible Factor-1 (HIF-1beta) on Western blots....
Biology Products: